Complete Story
01/18/2012
Article on Drug Shortages
Shortages of some injectable cancer drugs have created an opening for dangerous unapproved versions of Roche Holding AG’s Herceptin and Amgen Inc.’s Neupogen to be sold to clinics and other health-care providers, the U.S. said.
